- In January 2024, Center Point Bio-Tech, LLC (CPB) unveiled AlphaION at the 2024 Veterinary Meeting & Expo in the U.S. This innovative, patent-pending diagnostic system is designed specifically for veterinary practices
- In November 2023, Antech inaugurated a new veterinary diagnostics laboratory in Warwick, U.K., which will enhance the company’s laboratory network across the region. This state-of-the-art facility is equipped with advanced technology to provide comprehensive diagnostic services, improving turnaround times for test results
- In March 2023, QIAGEN N.V. formed a partnership with Servier to create a companion diagnostic test for TIBSOVO, an isocitrate dehydrogenase-1 (IDH1) inhibitor. This solution was launched for the treatment of Acute Myeloid Leukemia (AML), a type of blood cancer. As part of this collaboration, QIAGEN will develop and validate a real-time in vitro PCR test for detecting IDH1 gene mutations in AML patients using whole blood and bone marrow aspirates
- In August 2022, PepiPets introduced a new mobile diagnostic testing service, enabling clients to obtain diagnostic testing for their pets in the comfort of their own homes. The company aims for this at-home testing service to enhance pet comfort during procedures and reduce the time spent traveling to in-person office visits
- In March 2022, Companion Animal Health established a strategic partnership, which includes an equity investment, with HT BioImaging to co-brand and exclusively market the HTVet product in the U.S. and Canada
Frequently Asked Questions
The market is segmented based on Segmentation By Product (Instruments and Reagents and Consumables), Technology (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Haematology, Urinalysis, and Others), Animal Type (Companion Animals and Livestock Animals), Disease Type (Infectious Diseases, Non-infectious Diseases, Hereditary, Congenital, and Acquired Diseases, General Ailments, and Structural and Functional Diseases), Species (Bovine, Camelid, Canine and Feline, Caprine, Equine, Ovine, Porcine, Avian, and Others), End User (Reference Laboratories, Veterinary Hospitals and Clinics, Point-of-Care/In-House Testing, Research Institutes, and Universities) – Industry Trends and Forecast to 2031
.
The Global Veterinary Diagnostics Market size was valued at USD 3.06 USD Billion in 2023.
The Global Veterinary Diagnostics Market is projected to grow at a CAGR of 8.55% during the forecast period of 2024 to 2031.
The major players operating in the market include Market players covered: Almac, Element Materials Technology Group Limited, Eurofins Scientific, PPD Development LP, Source BioScience, Intertek Group plc, Laboratory Corporation of America, BioReliance Corporation, Charles River Laboratories, WuXi AppTec, Anacura, LGC Ltd, Medpace Hldgs, Syneos Health, PRA Health Sciences, STERIS plc, Merck Group KGaA, PPD -.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
